Probiotics help in a short list of specific situations, and the clearest is protecting the gut during a course of antibiotics, where named strains like Saccharomyces boulardii and Lactobacillus rhamnosus GG lower the diarrhea antibiotics often cause. They give modest help in irritable bowel syndrome. The category is sold on a much larger promise, that everyone should take one every day for general gut health, and that is where the evidence thins: in healthy people a daily probiotic produces no lasting change, and two large trials found it did nothing for children's acute diarrhea.
For most people, fermented foods cover the general case and a supplement is worth buying only for a specific job. A few groups, chiefly the immunocompromised and the critically ill, should treat a probiotic as a medical decision to make with a clinician.
Findings & Outcomes
What It Is
A probiotic is a live microorganism, a bacterium or a yeast, taken in enough quantity to reach the gut alive. Hundreds of different organisms are sold under that single word, and they do not share one effect. A benefit shown for Saccharomyces boulardii in one situation says nothing about a Lactobacillus blend in another. Effects belong to a named strain, at a named dose, used for a named job, so two capsules both labeled probiotic can carry completely different organisms with completely different evidence, or none. Read the label for the exact species and strain. That is how you tell whether a product has trials behind it.
Anatomy of the Practice
1A live organism that passes through
A probiotic is a live bacterium or yeast that travels through your digestive tract. Most strains do not settle in and colonize; they act while they are passing through and while you keep taking them. This is why any effect tends to fade once you stop, and why the strain and the dose on the label matter more than the word probiotic on the front.
2During a course of antibiotics
Antibiotics clear out resident gut bacteria along with the infection, and that emptied space is where antibiotic-associated diarrhea and, less often, a Clostridioides difficile overgrowth take hold. A probiotic taken during the course competes for that space and limits how far those organisms can grow. Saccharomyces boulardii is a yeast, so ordinary antibacterial antibiotics do not kill it, which is one reason it is a common choice for this window.
3In an already healthy gut
In a person who is already well, the resident microbiome is a stable community that tends to return to its own set point after a supplement stops. That stability is the reason a daily probiotic does not reliably reshape a healthy gut, and it is the mechanism behind the finding that general daily use in healthy people has little lasting effect.
What It Does
The findings sort by situation: the same strain that clearly helps in one setting does nothing measurable in another. The strongest evidence is around antibiotics. Across 63 trials in 11,811 people, taking a probiotic during a course of antibiotics prevented about one case of diarrhea for every 13 treated, and two single organisms, Saccharomyces boulardii and Lactobacillus rhamnosus GG, have the clearest trial evidence for that job. The same protection holds in children, and higher-dose products worked better there. Given alongside antibiotics a probiotic also lowers the rate of Clostridioides difficile diarrhea, a serious gut infection, and that benefit is largest for people whose baseline risk is already high, such as older hospitalized patients on broad-spectrum antibiotics.
Irritable bowel syndrome is the next tier down. The pooled benefit is modest and it turns on the strain, so a multi-strain product is worth an eight-week trial with the understanding that a given one may help a lot or do nothing.
The broad promise is where the evidence stops. In healthy people a daily probiotic does not lastingly change the gut community, so a capsule for general gut health is not supported. And in nearly 1,900 children with an ordinary stomach bug, a probiotic worked no better than placebo for the diarrhea itself. The graded record below places every use, wins and nulls together, at the strength of its own evidence.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Digestion
In two large trials, probiotics were no better than placebo for children’s acute diarrhea (RR 0.96)
For a child with an ordinary stomach bug and diarrhea, two large, careful trials found that a five-day probiotic course worked no better than a placebo. This is one of the clearest examples of a probiotic use that sounds obvious and did not hold up.
Two large randomized, placebo-controlled trials published together in the New England Journal of Medicine tested probiotics for acute gastroenteritis in children. Schnadower 2018 gave Lactobacillus rhamnosus GG (10 billion colony-forming units twice daily for 5 days) to 971 children and found moderate-to-severe gastroenteritis within 14 days in 11.8% versus 12.6% on placebo, relative risk 0.96 (95% CI 0.68 to 1.35, P=0.83). Freedman 2018 gave a combination of L. rhamnosus R0011 and L. helveticus R0052 to 886 children and found moderate-to-severe gastroenteritis in 26.1% versus 24.7% on placebo, odds ratio 1.06 (95% CI 0.77 to 1.46, P=0.72). Neither improved duration of diarrhea or vomiting. Both concluded the probiotic did not help.
The studies · 2
Schnadower 2018, N Engl J Med (L. rhamnosus GG) · N Engl J Med
Freedman 2018, N Engl J Med (combination probiotic) · N Engl J Med
Probiotics with antibiotics prevent one case of diarrhea for every 13 people treated
Taking a probiotic alongside a course of antibiotics lowers the chance of the loose stools antibiotics often cause. Across a large body of trials it prevented about one case for every 13 people who took one.
A systematic review and meta-analysis of 63 randomized controlled trials in 11,811 participants (Hempel 2012, JAMA) found probiotics reduced the risk of antibiotic-associated diarrhea versus control, pooled relative risk 0.58 (95% CI 0.50 to 0.68), risk difference -0.07 (95% CI -0.10 to -0.05), number needed to treat 13 (95% CI 10.3 to 19.1). The trials pooled many different organisms and doses, so the estimate is an average across a heterogeneous literature rather than a result for one product; the review noted the evidence did not let it say which strain was best.
The study · 1
Hempel 2012, JAMA · JAMA
Saccharomyces boulardii cut antibiotic diarrhea from about 19 to about 9 in 100
Saccharomyces boulardii, a probiotic yeast, roughly halved antibiotic-associated diarrhea in the trials that tested it, dropping it from about 19 in 100 people to about 9 in 100.
A systematic review with meta-analysis of 21 randomized controlled trials in 4,780 participants (Szajewska 2015, Aliment Pharmacol Ther) found Saccharomyces boulardii reduced the risk of antibiotic-associated diarrhea from 18.7% in controls to 8.5%, relative risk 0.47 (95% CI 0.38 to 0.57). S. boulardii is a yeast, so ordinary antibacterial antibiotics do not kill it, which is one reason it is a common choice during an antibiotic course. This is a strain-specific result rather than a claim about probiotics in general.
The study · 1
Szajewska 2015, Aliment Pharmacol Ther (S. boulardii) · Aliment Pharmacol Ther
Lactobacillus rhamnosus GG cut antibiotic diarrhea from about 22 to about 12 in 100
Lactobacillus rhamnosus GG, one of the most studied single strains, roughly halved antibiotic-associated diarrhea, from about 22 in 100 people to about 12 in 100.
A systematic review with meta-analysis of 12 randomized controlled trials in 1,499 participants (Szajewska 2015, Aliment Pharmacol Ther) found Lactobacillus rhamnosus GG reduced antibiotic-associated diarrhea from 22.4% in controls to 12.3%, relative risk 0.49 (95% confidence interval 0.29 to 0.83). Like the S. boulardii result, this is tied to one named strain; it is the reason S. boulardii and L. rhamnosus GG are the two organisms most often named for this specific job.
The study · 1
Szajewska 2015, Aliment Pharmacol Ther (L. rhamnosus GG) · Aliment Pharmacol Ther
In children on antibiotics, probiotics cut diarrhea from about 19 to about 8 in 100
In children taking antibiotics, a probiotic cut the rate of diarrhea from about 19 in 100 to about 8 in 100, and the higher-dose products worked better than low-dose ones.
A Cochrane systematic review and meta-analysis of 23 studies in 3,938 children (Goldenberg 2015) found probiotics reduced antibiotic-associated diarrhea from 19% (364 of 1,906) in controls to 8% (163 of 1,992), relative risk 0.46 (95% CI 0.35 to 0.61). A dose subgroup analysis favored higher doses (5 billion or more colony-forming units per day). The best-supported organisms in the pediatric trials were, again, Lactobacillus rhamnosus GG and Saccharomyces boulardii.
The study · 1
Goldenberg 2015, Cochrane Database Syst Rev (pediatric AAD) · Cochrane Database Syst Rev
Probiotics with antibiotics cut C. difficile diarrhea from about 4 to about 1.5 in 100
Given alongside antibiotics, a probiotic lowered the rate of C. difficile diarrhea, a serious gut infection, from about 4 in 100 to about 1.5 in 100. The benefit was largest in people whose baseline risk was already high.
A Cochrane review and meta-analysis of 31 trials in 8,672 people (Goldenberg 2017) found probiotics, taken with antibiotics, reduced Clostridioides difficile-associated diarrhea from 4.0% (164 of 4,147) in controls to 1.5% (70 of 4,525), relative risk 0.40 (95% CI 0.30 to 0.52), number needed to treat 42. In the subgroup at high baseline risk (control-group rate above 5%) the effect was larger, relative risk 0.30 (95% CI 0.21 to 0.42), number needed to treat 12. Where baseline risk was low, the absolute benefit was small.
The value is greatest during a high-risk antibiotic course, for example an older hospitalized person on broad-spectrum antibiotics, and smaller for a young healthy person on a short outpatient course.
The study · 1
Goldenberg 2017, Cochrane Database Syst Rev (C. difficile) · Cochrane Database Syst Rev
Probiotics give modest relief in irritable bowel syndrome (RR 0.79 versus placebo)
For irritable bowel syndrome, probiotics helped somewhat more people feel better than placebo did, with improvements in abdominal pain, bloating and wind. The effect is modest and it is not clear which product to reach for.
A systematic review and meta-analysis (Ford 2014, Am J Gastroenterol) pooled 43 randomized controlled trials and found the relative risk of IBS symptoms persisting was 0.79 (95% CI 0.70 to 0.89) with probiotics versus placebo, with benefit seen for global IBS symptoms, abdominal pain, bloating and flatulence. The authors concluded probiotics are effective for IBS but that which individual species and strains are most beneficial remains unclear. The effect is modest, and the uncertainty about strain is the practical limit.
The study · 1
Ford 2014, Am J Gastroenterol · Am J Gastroenterol
Whether probiotics help irritable bowel depends on the strain: 7 of 11 recent trials improved symptoms
Whether a probiotic helps IBS depends heavily on which one it is. In a set of recent trials, roughly two-thirds improved symptoms and a third did nothing, with multi-strain products taken for at least eight weeks looking best.
A systematic review (Dale 2019, Nutrients) of 11 recent randomized controlled trials found that 7 (63.6%) reported a significant improvement in IBS symptoms versus placebo while the remainder did not, and that effects were more distinct in trials using multi-strain supplements for 8 weeks or longer. Across these trials the results split: probiotics for IBS depend on the strain and the duration, which is why the pooled benefit holds even though the direction for any one product is mixed.
If trying one for IBS, give a multi-strain product a fair run of at least eight weeks, and if it has done nothing by then, stop rather than keep paying for it.
The study · 1
Dale 2019, Nutrients (IBS systematic review) · Nutrients
In healthy adults, probiotics did not lastingly change gut bacteria or blood lipids
The idea that a healthy person should take a daily probiotic to improve general gut health is not backed by the research. In healthy adults, probiotics did not lastingly change the gut bacteria, and the general-wellness benefits are inconsistent.
A systematic review of probiotic supplementation in healthy adults (Khalesi 2019, Eur J Clin Nutr) found some short-term signals in immune, gastrointestinal and female reproductive measures, but concluded that the evidence did not support probiotics causing persistent changes in the gut microbiota or improving blood lipid profiles in healthy adults. In healthy people the resident microbiome tends to return to its own set point once supplementation stops. The established benefits of probiotics are specific strain-and-condition pairings, not a general daily tonic for people who are already well.
The study · 1
Khalesi 2019, Eur J Clin Nutr (healthy adults review) · Eur J Clin Nutr
How It Works
The mechanism is competition and occupation. A strain taken in enough numbers competes with other gut organisms for space and food, changes the local chemistry, and interacts with the gut lining and immune tissue while it is present. The effect is local and temporary, which is why it helps only in the right situation. During antibiotics the resident community has been thinned, so there is room for a probiotic to establish itself while you take it, and this is where the trial evidence is strongest. In a settled, healthy gut there is no such room, and the same organism has little to do.
The same strain that prevents antibiotic-associated diarrhea does nothing measurable in a healthy gut, because the effect is local and depends on the room an antibiotic course opens up.
A benefit belongs only to the strain that showed it: a result for Saccharomyces boulardii during antibiotics does not transfer to a different organism used for a different purpose. For the fiber that feeds the bacteria you already have, see fiber, and for the dietary pattern that carries all of this, whole foods.
Getting It Right
Ways to Do It
Match the probiotic to a specific job. Most people do not need a daily one at all; the value shows up in particular situations, and food covers the general case better than a capsule does.
For the general case, food beats a supplement. Live-culture yogurt and kefir, sauerkraut and kimchi, miso, tempeh and other traditionally fermented foods deliver a changing mix of organisms inside a whole diet, and they carry fiber and other nutrients with them. This is the low-effort, food-first version of the idea, and it sits inside the wider pattern on the [whole foods](/go/integrative/practice/whole-foods) page.
When there is a specific job to do, the strain is the decision. For diarrhea during a course of antibiotics, the two organisms with the clearest trial support are Saccharomyces boulardii and Lactobacillus rhamnosus GG, and higher-dose products worked better in the pediatric trials. For irritable bowel syndrome, a multi-strain product given a run of at least eight weeks is what the better trials used. Read the label for the exact species and strain, not just the word probiotic.
For a healthy person seeking general gut health, and for a child with an ordinary viral stomach bug, the trial evidence does not support a probiotic, so the better move is to save the money and eat well instead. Reserve the supplement for the situations where a specific strain has been shown to help, and let food carry the rest.
Go Deeper
- Whole foods: the dietary pattern that carries fermented foods and fiber, and the better-supported answer to general gut health than a single supplement.
- Fiber: the food that feeds the resident bacteria you already have, with the clearest dose-response curve in nutrition and the widest shortfall.
- Type 2 diabetes: a condition where gut and metabolic claims for probiotics are made freely, held to the same per-claim standard as everything else.
The Chinese Medicine View
Probiotics as isolated, cultured strains in a capsule are a modern product, so there is no classical entry for them. What Chinese medicine does have is a long relationship with fermentation and with the digestive function these products aim at, offered here as a lens rather than as evidence.
Digestion in Chinese medicine belongs to the Spleen and Stomach, the pair that receives food and transforms it into the substances the body runs on. When that transforming function is weak, the classical picture is loose stools, bloating, fatigue and a heavy feeling, much of the same territory these products are marketed toward. The tradition also uses fermented preparations directly: Shen Qu, medicated leaven, is a fermented cake of wheat flour and herbs used to move food stagnation and support digestion, and Dan Dou Chi, fermented soybean, is a long-standing item in the materia medica. Both already sit in our library. So the idea that a fermented food can aid the Spleen and Stomach in breaking down and moving what you eat is native to the tradition.
A practitioner would not read this as a reason for everyone to take a daily capsule. The Spleen dislikes damp, and some of the dairy-based fermented foods can be damp-forming for a person who already tends that way, so the tradition would match the food to the constitution instead of prescribing one thing for all. Used this way, the framing lines up well with the modern finding: fermented food supports digestion as part of a whole diet, and neither the tradition nor the modern evidence supports a general daily supplement for a well person.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
For healthy people, probiotics are generally safe, with mild gas or bloating at first
A review of the risk and safety of probiotics (Doron 2015, Clin Infect Dis) concluded that probiotics are generally safe for most people, with the most common adverse effects being mild and gastrointestinal, such as gas and bloating. For the general, healthy population the safety record across a large trial literature is reassuring. The serious risks that do exist are concentrated in specific vulnerable groups, which is a separate matter covered below.Doron 2015, Clin Infect Dis (risk and safety of probiotics)
In immunocompromised or critically ill people, probiotics can cause bloodstream infection
A review of probiotic risk and safety (Doron 2015, Clin Infect Dis) describes that the principal serious hazard of live probiotics is systemic infection, when the organism moves from the gut into the bloodstream, alongside deleterious metabolic activity, excessive immune stimulation in susceptible people, and gene transfer. These events are rare overall but are concentrated in vulnerable groups: people with weakened immune systems, critical illness, or an indwelling central venous catheter. Both bacterial bloodstream infection and yeast fungemia have been reported in such patients. For these groups, a probiotic is a medical decision, not a self-care one.Doron 2015, Clin Infect Dis (risk and safety of probiotics)
In severe acute pancreatitis, a probiotic mixture raised deaths to 16 in 100 versus 6
A randomized, double-blind, placebo-controlled trial (Besselink 2008, Lancet) gave a multispecies probiotic preparation or placebo to 298 patients with predicted severe acute pancreatitis. The probiotic did not reduce infectious complications and was associated with increased mortality: 24 of 152 patients (16%) in the probiotic group died compared with 9 of 144 (6%) on placebo. The authors concluded that probiotic prophylaxis should not be given to this category of patients. It stands as direct trial evidence that live probiotics can cause harm in the critically ill, not only in theory.Besselink 2008, Lancet (PROPATRIA trial)
The immunocompromised, the critically ill, and central lines
For a person whose immune defenses are down, who is seriously unwell, or who has a central venous catheter, live probiotic organisms can cross from the gut into the bloodstream and cause a systemic infection, and both bacterial infection and yeast fungemia have been reported. In a trial of critically ill patients with severe pancreatitis, a probiotic mixture was linked to more deaths and did not reduce infections. If you or someone you care for is in one of these groups, treat a probiotic as a medical decision to make with a clinician.
What is on the label may not be in the bottle
Probiotic supplements are loosely regulated, and the live-organism count printed on the label often does not survive shipping, shelf time and stomach acid. Look for a product that names the exact species and strain and states the dose as colony-forming units guaranteed through the end of the shelf life, and store it as the label directs, since many strains need refrigeration to stay alive.
Timing around the antibiotic dose
If you are taking a bacterial probiotic during a course of antibiotics, separating the two by about two hours keeps the antibiotic from killing the strains you just took. This does not apply to Saccharomyces boulardii, which is a yeast and is unaffected by antibacterial antibiotics, so it can be taken at any time.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Should I take a probiotic every day for general gut health?
For most healthy people, the research does not support it. In healthy adults, probiotics do not produce lasting changes in the gut bacteria, and the general-wellness benefits are inconsistent. The uses that hold up are specific strains for specific conditions, mostly around antibiotics and the gut. If your goal is a healthier gut in general, a diet built on whole foods, fiber and some fermented foods is the better-supported route than a daily capsule.
Do probiotics help if I am taking antibiotics?
Yes, this is the strongest use. Taken alongside a course of antibiotics, certain strains lower the risk of antibiotic-associated diarrhea, and in higher-risk settings they lower the risk of Clostridioides difficile diarrhea as well. The two organisms with the clearest evidence are Saccharomyces boulardii and Lactobacillus rhamnosus GG. Separate a bacterial probiotic from the antibiotic dose by about two hours; the yeast, Saccharomyces boulardii, can be taken any time.
Does the strain matter, or are they all the same?
The strain is most of what matters. Two products both labeled probiotic can hold completely different organisms with completely different evidence, so the general word tells you almost nothing. Benefits shown for one named strain do not transfer to another. For antibiotic-associated diarrhea, look specifically for Saccharomyces boulardii or Lactobacillus rhamnosus GG; for irritable bowel syndrome, the better trials used multi-strain products over at least eight weeks.
Can I get the benefit from food instead of a pill?
For general gut health, food is the better answer. Traditionally fermented foods, live-culture yogurt and kefir, sauerkraut, kimchi, miso and tempeh, deliver a changing mix of organisms along with fiber and other nutrients, inside a whole diet rather than as one isolated strain. A supplement earns its place for a specific job, such as protecting the gut during antibiotics, not as a routine you keep alongside eating well.
How long until a probiotic does anything, and do the effects last?
It depends on the job. For preventing antibiotic-associated diarrhea, the probiotic works during the course itself. For irritable bowel syndrome, the better trials ran eight weeks or more before judging whether a product helped, so a fair trial is a couple of months. Because most strains pass through instead of colonizing, benefits generally hold only while you keep taking it, and a healthy gut returns to its own baseline once you stop.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 13 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.